C Haas

Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus

Volker Schirrmacher, C Haas, R Bonifer et al. · Gene Therapy · 1999 · 153 citations

Medicine, Immunology, Oncology +17

New designer drug α‐pyrrolidinovalerophenone (PVP): studies on its metabolism and toxicological detection in rat urine using gas chromatographic/mass spectrometric techniques

Christoph Sauer, Frank T. Peters, C Haas et al. · Journal of Mass Spectrometry · 2009 · 94 citations

Pharmacy, Pharmacology, Toxicology +17

High urinary excretion of lipid peroxidation-derived DNA damage in patients with cancer-prone liver diseases

Jagadeesan Nair, Petcharin Srivatanakul, C Haas et al. · Mutation research. Fundamental and molecular mechanisms of mutagenesis · 2009 · 58 citations

Medicine, Biochemistry, Oncology +14

Introduction of adhesive and costimulatory immune functions into tumor cells by infection with Newcastle Disease Virus.

C Haas, C Ertel, Roswitha Gerhards et al. · International Journal of Oncology · 1998 · 40 citations

Life Sciences, Immunology, Oncology +13

Virus potentiation of tumor vaccine T-cell stimulatory capacity requires cell surface binding but not infection.

Volker Schirrmacher, C Haas, R Bonifer et al. · PubMed · 1997 · 34 citations

Life Sciences, Immunology, Oncology +17